Clinical trial
Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated…
NCT00487656 · Artisan Pharma, Inc., Industry · Completed
Key facts
| NCT number | NCT00487656 |
|---|---|
| Title | Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Phase-2B Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects With Sepsis and Disseminated Intravascular Coagulation |
| Lead sponsor | Artisan Pharma, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sepsis, Disseminated Intravascular Coagulation |
| Intervention type | Drug |
| Interventions | ART-123, placebo |
| Enrollment | 750 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | Aug 1, 2010 |
| First posted | Jun 18, 2007 |
| Last update posted | May 18, 2011 |
| Countries | Canada, Malaysia, Thailand, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: